Document Type : Original Article

Authors

1 Student Research Committee, Department of Parasitology and Mycology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

2 Student Research Committee, Department of Parasitology and Mycology, Hamadan University of Medical Sciences, Hamadan, Iran

3 Department of Parasitology and Mycology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

4 Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Abstract

Background and aims: Parasitic infections, especially opportunistic parasites, can cause serious problems for immunocompromised patients. In this regard, this study aimed to evaluate parasitic infections in cancer patients undergoing chemotherapy after referring to Kashani hospital of Shahrekord from January to May 2018.
Methods: In this cross-sectional descriptive study, 750 stool samples were collected from 250 cancer patients undergoing chemotherapy (three fecal samples from each patient) and sent to the Parasitology Laboratory of Shahrekord University of Medical Sciences. All samples were examined macroscopically and microscopically through the direct method and a specific acid-fast staining method. To confirm the microscopic results, DNA was extracted from isolated parasites and amplification was performed by the polymerase chain reaction with the specific primers on positive samples.
Results: In this study, 106 (42.4%) and 144 (57.6%) patients were males and females, respectively. In addition, 187 (74.8%) and 63 (25.2%) of them were living in urban and rural areas, respectively. In terms of the education level, most patients had a low level of literacy. Further, 12 (4.8%) patients were infected with intestinal parasites that including, 7 (2.8%), and 5 (2%) samples were infected with Blastocystis hominis and Giardia lamblia, respectively.
Conclusion: The results of this study showed that B. hominis and G. lamblia are the most prevalent parasites in cancer patients undergoing chemotherapy. Although the prevalence of intestinal parasites in cancer patients was low, these findings should not be contrary to the need for healthcare regarding the prevention of parasitic infections in cancer patients.

Keywords

Main Subjects

1. Farmer RD, Lawrenson R. Lecture Notes on Epidemiology and Public Health Medicine. Malden, Mass: Wiley-Blackwell;2004.
2. Soleymani E, Davoodi L, Azami D. The prevalence of intestinal parasitic infections among the mentally retarded patients in Lamook Rehabilitation Center of Qaemshahr, Mazandaran province, 2015. Tabari Biomedical Student Research Journal. 2016;2(1):1-5. [Persian].
3. Al-Braiken FA. Is intestinal parasitic infection still a public health concern among Saudi children? Saudi Med J. 2008;29(11):1630-5.
4. Garcia LS. Diagnostic medical parasitology. In: Truant AL, ed.Manual of Commercial Methods in Clinical Microbiology. Washington, DC: American Society for Microbiology; 2001. p. 274-305.
5. Mohammadi-Ghalehbin B, Pezeshki A, Kohansal MH, Esmaeilnezhad G. Frequency of intestinal parasites in patients with malignancy in Ardabil province, northwest Iran. J Hum Environ Health Promot. 2017;2(2):118-24. doi: 10.29252/ jhehp.2.2.118.
6. World Health Organization (WHO). National Cancer Control Programmes: Policies and Managerial Guidelines. Geneva: WHO; 2002.
7. Garcia LS. Diagnostic Medical Parasitology. American Society for Microbiology; 2006.
8. Cuomo MJ, Noel LB, White DB. Diagnosing Medical Parasites: A Public Health Officers Guide to Assisting Laboratory and Medical Officers. Randolph, NJ: Air Education and Training Command; 2009.
9. Pandey PK, Verma P, Marathe N, Shetty S, Bavdekar A, Patole MS, et al. Prevalence and subtype analysis of blastocystis in healthy Indian individuals. Infect Genet Evol. 2015;31:296-9. doi: 10.1016/j.meegid.2015.02.012.
10. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492.
11. Sulaiman IM, Fayer R, Bern C, Gilman RH, Trout JM, Schantz PM, et al. Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis. 2003;9(11):1444-52. doi: 10.3201/eid0911.030084.
12. Tamizhazhagan V, Pugazhendy K. Social and economic burden of cancer on 2020-minireview. J Biol Med Sci. 2017;1(2):103.
13. Abdel-Magied AA, El-Ghanam WA, El-Nemr HI, El-Henawy AA. Prevalence of intestinal parasites in cancer therapy recipients with concurrent diarrhea. Int J Trop Dis Health. 2016;15(1):1-7. doi: 10.9734/ijtdh/2016/24379.
14. Centers for Disease Control and Prevention (CDC). Expected New Cancer Cases and Deaths in 2020. Available from: https:// www.cdc.gov/cancer/dcpc/research/articles/cancer_2020.htm.
15. Danaei M, Haghdoost A, Momeni M. An epidemiological review of common cancers in Iran; a review article. Iran J Blood Cancer. 2019;11(3):77-84.
16. Rivera-Luna R, Cárdenas-Cardos R, Martínez-Guerra G, Ayón A, Leal C, Rivera-Ortegón F. Childhood acute leukemia and intestinal parasitosis. Leukemia. 1989;3(11):825-6.
17. Sanad MM, Thagfan FA, Al Olayan EM, Almogren A, Al Hammaad A, Al-Mawash A, et al. Opportunistic coccidian parasites among Saudi cancer patients presenting with diarrhea: prevalence and immune status. Res J Parasitol. 2014;9(2):55-63. doi: 10.3923/jp.2014.55.63. 
18. Mahmoudi MR, Rahmati B. Coinfection of Toxoplasma gondii and intestinal parasites among elderly immunocompromised patients. Elder Health J. 2020;6(1):31-5. doi: 10.18502/ehj. v6i1.3413. 
19. Guarner J, Matilde-Nava T, Villaseñor-Flores R, Sanchez- Mejorada G. Frequency of intestinal parasites in adult cancer patients in Mexico. Arch Med Res. 1997;28(2):219-22. 
20. Rudrapatna JS, Kumar V, Sridhar H. Intestinal parasitic infections in patients with malignancy. J Diarrhoeal Dis Res. 1997;15(2):71-4. 
21. Menon BS, Abdullah MS, Mahamud F, Singh B. Intestinal parasites in Malaysian children with cancer. J Trop Pediatr. 1999;45(4):241-2. doi: 10.1093/tropej/45.4.241. 
22. Aksoy U, Erbay A, Akisu C, Apa H, Ozkoç S, Oztürk S. Intestinal parasites in children with neoplasms. Turk J Pediatr. 2003;45(2):129-32. 23. Jeske S, Bianchi TF, Moura MQ, Baccega B, Pinto NB, Berne MEA, et al. Intestinal parasites in cancer patients in the South of Brazil. Braz J Biol. 2018;78(3):574-8. doi: 10.1590/1519- 6984.175364. 
24. Zabolinejad N, Berenji F, Bayati Eshkaftaki E, Badeii Z, Banihashem A, Afzalaqaei M. Intestinal parasites in children with lymphohematopoietic malignancy in Iran, Mashhad. Jundishapur J Microbiol. 2013;6(6):e7765. doi: 10.5812/ jjm.7765. 
25. Salehi S, Elmi T, Meamar AR, Basi A, Mirhosseini A, Najm M, et al. Investigating the prevalence of enteric opportunistic parasitic infections among cancer patients of a teaching hospital. Int J Hosp Res. 2018;7(1):12-22. doi: 10.15171/ ijhr.2018.xx. 
26. Azizi M, Houshyar H, Mousavi GA, Arbabi M, Zahiri A. Investigation the relationship between chemotherapy and intestinal parasitic infections in cancer patients undergoing chemotherapy. J Iran Med Council. 2012;30(1):42-8. [Persian]. 
27. Esteghamati A, Khanaliha K, Bokharaei-Salim F, Sayyahfar S, Ghaderipour M. Prevalence of intestinal parasitic infection in cancer, organ transplant and primary immunodeficiency patients in Tehran, Iran. Asian Pac J Cancer Prev. 2019;20(2):495-501. doi: 10.31557/apjcp.2019.20.2.495. 
28. Rasti S, Hassanzadeh M, Hooshyar H, Momen-Heravi M, Mousavi SGA, Abdoli A. Intestinal parasitic infections in different groups of immunocompromised patients in Kashan and Qom cities, central Iran. Scand J Gastroenterol. 2017;52(6- 7):738-41. doi: 10.1080/00365521.2017.1308547. 
29. Monsef AR, Hashemi SH, Abbasi M, Taherkhani H, Shalchi Z, Eliasi A. Frequency of intestinal parasites in patients with malignancy, admitted in oncology ward of Sina hospital, Hamadan, Iran. Journal of Gorgan University of Medical Sciences. 2008;9(4):51-5. 
30. Zorina T, Styche A. Infectious diseases in cancer patients: an overview. In: Shurin M, Thanavala Y, Ismail N, eds. Infection and Cancer: Bi-Directorial Interactions. Cham: Springer; 2015. p. 295-311. doi: 10.1007/978-3-319-20669-1_14. 
31. Klastersky J, Aoun M. Opportunistic infections in patients with cancer. Ann Oncol. 2004;15 Suppl 4:iv329-35. doi: 10.1093/ annonc/mdh947. 32. Hazrati Tappeh K, Maleki D, Mohammadzadeh H, Zarikar B. Evaluation of prevalence of intestinal parasites in adult patients with or without gastrointestinal manifestations rederring to oncology clinic of Urmia Imam Khomeini hospital. Studies in Medical Sciences. 2011;22(4):309-14. [Persian]. 
33. Botero JH, Castaño A, Montoya MN, Ocampo NE, Hurtado MI, Lopera MM. A preliminary study of the prevalence of intestinal parasites in immunocompromised patients with and without gastrointestinal manifestations. Rev Inst Med Trop Sao Paulo. 2003;45(4):197-200. doi: 10.1590/s0036- 46652003000400004. 
34. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403. doi: 10.1016/j. ejca.2012.12.027. 
35. Togeh GR, Keihani M, Athari A, Sadafi H. Parasitic infestation in cancer patients chemotherapy. Tehran Univ Med J. 2000;58(1):52-8. [Persian]. 
36. Lewandowska AM, Rudzki M, Rudzki S, Lewandowski T, Laskowska B. Environmental risk factors for cancer-review paper. Ann Agric Environ Med. 2019;26(1):1-7. doi: 10.26444/ aaem/94299. 
37. Niazi S, Mazlomi S, Shirzad MR, Mokamelkande A, Ahmadi F. Survey the outbreak of giardiasis among food supply and distribution staff of south pars economic zone petrochemicals. J Environ Health Eng. 2013;1(1):37-43. doi: 10.18869/ acadpub.jehe.1.1.37. 
38. Rahimi-Esboei B, Gholami S, Ghorbani A, Pourhajibagher M, Hassannia H, Shaban R. The prevalence of intestinal parasites among patients referring to health center in central areas of Mazandaran province, Iran. Lab Sci. 2012;6(2):19-25. 
39. Badparva E, Ezatpour B, Mahmoudvand H, Behzadifar M, Behzadifar M, Kheirandish F. Prevalence and genotype analysis of blastocystis hominis in Iran: a systematic review and meta-analysis. Arch Clin Infect Dis. 2017;12(1):e36648. doi: 10.5812/archcid.36648. 
40. Amin N, Tirger Fakhri H, Hossini V, Ziaei H, Dadashi A, Rahimi B, et al. Intestinal Parasitic Infections in Patients Attending Gastrointestinal Clinics. Journal of Mazandaran University of Medical Sciences. 2017;26(146):191-5. [Persian]. 
41. Abasian L, Talebi F, Delpisheh A. A meta-analysis of Giardia lamblia in Iran. Afr J Microbiol Res. 2013;7(15):1343-8. doi: 10.5897/ajmr12.1205. 
42. Berahmat R, Mahami-Oskouei M, Rezamand A, Spotin A, Aminisani N, Ghoyounchi R, et al. Cryptosporidium infection in children with cancer undergoing chemotherapy: how important is the prevention of opportunistic parasitic infections in patients with malignancies? Parasitol Res. 2017;116(9):2507-15. doi: 10.1007/s00436-017-5560-5. 
43. Berenji F, Zabolinezhad N, Hiradfar S, Kianifar H, Badeii Z, Banihashem S. Cryptosporidium infection in pediatric patients with lymphohematopoietic mphohematopoietic malignancies. Iran J Pediatr. 2007;17(3):247-251. [Persian].